We aim to make this site as accessible as possible and therefore have provided the settings below to use if you are finding it difficult to view this website. See the SFO Accessibility Statement for more information.

Where it is appropriate to provide a Welsh translation, you can switch to Cymraeg. See the Welsh Language Commissioner website for more information.

Use the settings button in the bottom right corner of the page to access these settings again.

Change to normal text size A Change to medium text size A Change to large text size A Adjust Text Size

We would like to use Analytics Cookies on our website. 

Turn these on below if you are happy with us collecting information on how our site is used, in order for us to improve the overall experience of our website. 

All other cookies are necessary and therefore by continuing to browse this website, you are agreeing to the usage of these cookies.

 See the SFO Privacy Policy for more information. 

Analytics Cookies

GlaxoSmithKline PLC

The GlaxoSmithKline PLC investigation focused on commercial practices by the company, its subsidiaries and associated persons. 

Following a detailed review of the available evidence and an assessment of the public interest there will be no prosecution in this case. For more information, see the full statement here.

Page published on 12 Nov 2014 | Page modified on 17 May 2021